| Accession Number | 0001628280-26-003734 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 28, 2026 |
| Document Date | Jan 26, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, CRO & Pres. Life Sciences | Common Stock | โ | Jan 26, 2026 | Sale | 75 | $202.73 | $15,204.75 | 16,431 | Direct | โ | View Details |